34 dokter terbaik untuk biopsi kulit di dunia

Kepala dokter dan profesor. Pakar Tingkat 1 di Pusat Kanker, West China Hospital, Universitas Sichuan (peringkat ke-2 di Tiongkok). Menyelesaikan fellowship pascadoktoral dalam radiologi intervensi di Rumah Sakit Umum PLA Tiongkok. Memimpin perawatan tim multidisiplin (MDT) untuk tumor kompleks. Pakar dalam onkologi intervensi minimal invasif untuk kanker hati, paru-paru, dan pankreas.

Akreditasi: Anggota Dewan WATA. Anggota komite CACA dan CMDA tentang intervensi, ablasi, biji radioaktif, dan nyeri. Pada tahun 2023, anggota direktur perdana Komite Perawatan Paliatif, Asosiasi Medis Sichuan. Anggota dewan redaksi Chinese Journal of Interventional Imaging and Therapy. Anggota dewan redaksi Chinese Journal of Pain Medicine.

Memimpin 2 proyek sains & teknologi provinsi dan 2 proyek NSFC. Memiliki 40+ makalah, dengan 30+ sebagai penulis pertama atau koresponden. Faktor dampak tertinggi: 10,73. Kohort karsinoma hepatoseluler (HCC): TACE + lenvatinib vs TACE + sorafenib. OS 18,97 vs 10,77 bulan. PFS 10,6 vs 5,4 bulan. ORR 66,8% vs 33,3%.

Profesor Luo Xiaoping adalah ahli radiologi intervensi yang diakui secara nasional dan otoritas terkemuka di Tiongkok Barat. Beliau mulai merintis intervensi vaskular pada awal 1990-an. Beliau membantu mendirikan Kelompok Intervensi di Rumah Sakit Afiliasi Kedua Universitas Medis Chongqing.

Beliau telah menyelesaikan lebih dari 100.000 prosedur intervensi, termasuk sekitar 4.000 kasus kompleks. Keterampilan utamanya meliputi TACE untuk karsinoma hepatoseluler, intervensi Budd-Chiari, TIPS, dan pemasangan stent bilateral satu tahap untuk obstruksi bilier hilar, dengan tingkat keberhasilan mendekati 100%. Beliau telah menjadi pembimbing magister sejak 2007. Beliau telah melatih banyak dokter, memandu kasus-kasus kompleks di lebih dari 40 rumah sakit besar di Tiongkok Barat, dan membantu membangun program intervensi. Beliau telah menerbitkan 32 makalah sebagai penulis pertama atau penulis korespondensi (22 inti CSCD, 4 inti Tiongkok, 6 CSCD diperluas).

Dr. Dov Zippel adalah ahli bedah onkologi dan kepala Pusat Payudara Meirav. Forbes Israel memasukkannya ke dalam daftar Dokter Terbaik pada tahun 2025. Ia menangani tumor payudara jinak dan ganas serta melanoma di Sheba Medical Center. Dr. Zippel menyelesaikan fellowship bedah onkologi di University of Calgary di Kanada.

• Melakukan operasi konservasi payudara dan prosedur invasif minimal untuk kanker kulit.
• Merawat pasien di Institut Imuno-Onkologi Ella Lemelbaum.
• Meneliti perawatan perioperatif untuk melanoma stadium III dan eksisi lesi payudara.
• Bekerja di Sheba Medical Center, yang menduduki peringkat ke-7 di dunia oleh Newsweek pada tahun 2026.

Profesor Xiao Yueyong adalah Kepala Dokter di Departemen Diagnostik Radiologi di Rumah Sakit Umum Tentara Pembebasan Rakyat Tiongkok. Beliau adalah pakar terkemuka dalam onkologi intervensi minimal invasif. Beliau menjabat sebagai presiden perdana WATA (2025–). Beliau adalah presiden Masyarakat Internasional (2020–) dan Asia (2012–) untuk Krioterapi. Beliau juga merupakan Wakil Kepala Kelompok Pakar NHC tentang peraturan ablasi tumor (2009–).

Beliau telah melakukan lebih dari 100.000 prosedur minimal invasif yang dipandu CT/MRI. Pekerjaannya mencakup ablasi kimia, RFA, MWA, krioablasi, dan NanoKnife (IRE). Beliau memperkenalkan dan memajukan ablasi NanoKnife di Tiongkok. Beliau memimpin standar nasional pertama untuk krioablasi tumor dan NanoKnife.

Penghargaan termasuk Penghargaan Kontribusi Khusus Nasional (Kehormatan seumur hidup). Beliau menerima Hadiah Pertama dari Asosiasi Pendidikan Kedokteran Tiongkok (2021). Beliau menerima dua Hadiah Kedua untuk Prestasi Medis Militer (2016, 2018) dan dua Hadiah Kedua dari Asosiasi Anti-Kanker Tiongkok (2019, 2022). Beliau dinobatkan sebagai Master Ablasi Asia. Catatan penelitiannya mencakup 13 paten Tiongkok. Beliau adalah peneliti utama untuk empat proyek NSFC dan satu subjek MOST. Beliau telah menerbitkan lebih dari 200 makalah, dengan lebih dari 110 sebagai penulis pertama atau koresponden dan lebih dari 40 di jurnal SCI. Beliau telah memimpin lebih dari 10 pedoman atau pernyataan konsensus ablasi.

Dokter lulus dari Fakultas Kedokteran Universitas Istanbul pada tahun 1986 dan menyelesaikan residensi dermatologi di Rumah Sakit Haydarpaşa Numune pada tahun 1990. Mengkhususkan diri dalam bedah dermatologi, dokter memiliki fokus klinis pada kanker kulit, krioterapi, pengobatan hiperhidrosis, dan penyakit kulit alergi. Dokter juga terampil dalam elektrokauterisasi, perawatan laser, dermatologi kosmetik, dermatoskopi, dan teknik peremajaan kulit seperti Botox. Dokter telah bekerja di berbagai institusi, termasuk Pusat Kesehatan Görele, Rumah Sakit Pelatihan dan Penelitian Fatih Sultan Mehmet, dan Rumah Sakit Regional Swasta Istanbul.<\/p>

Dr. Cemile Dilek Uysal adalah dokter spesialis kulit di Hisar Hospital Intercontinental di Istanbul. Beliau lulus dengan predikat kehormatan dari Universitas Akdeniz. Dr. Uysal menangani berbagai kondisi kulit, termasuk jerawat, eksim, dan psoriasis. Beliau juga menangani penyakit parasit seperti kudis dan gangguan rambut seperti alopecia.

• Spesialis dalam terapi pengobatan untuk jerawat serta penyakit kulit akibat virus atau bakteri.
• Menangani infeksi jamur dan kasus kompleks pruritus kronis atau gatal-gatal.
• Bekerja di Rumah Sakit Hisar, fasilitas terakreditasi JCI yang memenuhi standar keamanan tinggi.
• Memberikan perawatan di pusat yang melayani lebih dari 500.000 pasien internasional setiap tahunnya.

Dr. Elkhan Mammadov adalah seorang onkolog medis. Beliau berfokus pada diagnosis dan pengobatan kanker, termasuk kemoterapi sitotoksik, terapi hormon, terapi target (obat pintar), dan imunoterapi.

Pendidikan: Universitas Kedokteran Azerbaijan, MD (2004–2010). Universitas Istanbul, Fakultas Kedokteran Istanbul, pelatihan Penyakit Dalam (2014–2019). Rumah Sakit Universitas Istanbul Medipol Mega, pelatihan subspesialisasi Onkologi Medis (2019–2022).

Pengalaman: 5 tahun di Penyakit Dalam. 3 tahun di Onkologi Medis.

Keanggotaan: Masyarakat Onkologi Medis Turki. ESMO (Masyarakat Onkologi Medis Eropa). ASCO (Masyarakat Onkologi Klinis Amerika).

Dr. Christiane Thallinger adalah spesialis kanker kulit dan dermatologi onkologi di Wiener Privatklinik. Beliau adalah pakar yang diakui dalam menangani melanoma dan karsinoma sel basal di Austria. Dr. Thallinger berfokus pada penanganan komplikasi kulit yang disebabkan oleh terapi kanker. Sebelumnya, beliau menjabat sebagai dokter senior di Universitas Kedokteran Wina.

• Melakukan pemetaan tahi lalat digital dan dermatoskopi untuk deteksi dini kanker kulit.
• Menangani reaksi kulit kompleks yang disebabkan oleh kemoterapi dan imunoterapi.
• Melakukan eksisi tumor bedah, krioterapi, dan terapi fotodinamik.
• Melakukan penelitian tentang toksisitas kulit terkait imun untuk meningkatkan hasil pengobatan pasien.

Dr. Aleksandra Starosciak lulus dari Akademi Medis di Warsawa. Beliau telah menjadi spesialis bedah umum sejak tahun 2009. Beliau sedang menjalani pelatihan dalam bedah onkologi. Sejak tahun 2010, beliau bekerja di Departemen Bedah Onkologi di Rumah Sakit Holy Family di Warsawa. Beliau adalah anggota Masyarakat Bedah Onkologi Polandia. Beliau menghadiri konferensi ilmiah dan pelatihan di bidang bedah umum, onkologi, bedah plastik, dan USG payudara.

Beliau melakukan operasi payudara, termasuk pengangkatan tumor, rekonstruksi, dan mastektomi. Beliau juga melakukan prosedur jaringan lunak dan prosedur kecil, seperti pengangkatan lesi kulit dan nodul. Beliau melakukan bedah endokrin untuk lesi tiroid ganas dan jinak.

Beliau mendiagnosis penyakit payudara. Beliau melakukan biopsi payudara dengan bantuan vakum (mammotome) yang dipandu USG. Beliau juga melakukan biopsi jarum inti dan biopsi aspirasi jarum halus. Beliau melakukan biopsi tiroid dan videodermoskopi lesi kulit.

a.o. Univ. Prof. Dr. med. Tamara Kopp adalah dokter spesialis dermatologi dan venereologi bersertifikat. Beliau adalah pemilik JUVENIS Medical Center di Wina. Beliau memiliki pengalaman selama hampir 30 tahun. Beliau pernah bekerja di Harvard Skin Disease Research Center (1993–1997) dan menyelesaikan pelatihan spesialis di AKH Wina (1997–2004). Beliau menerima venia docendi/Profesor Madya pada tahun 2004. Dari tahun 2004 hingga 2012, beliau menjabat sebagai konsultan senior di AKH Wina, di mana beliau memimpin klinik alergi dan sebuah bangsal.

Fokus klinis beliau meliputi skrining kanker kulit dan bedah dermatologi. Beliau juga menawarkan layanan dermatologi estetik (toksin botulinum, asam hialuronat), kedokteran laser, radiofrequency microneedling, perawatan alergi, pengobatan gangguan pigmentasi, jerawat dan rosasea, chemical peel, serta terapi psoriasis.

Publikasi beliau mencakup Nature (2015; IL-23 pada psoriasis), EMBO Molecular Medicine (2014), Journal of Experimental Medicine, dan Journal of Investigative Dermatology. Penghargaan yang diterima meliputi Heinrich Auspitz Prize (2015), Theodor Billroth Prize (2004), dan UNILEVER Prize (2003). Beliau telah bersertifikat ISAC sejak tahun 2022 (berlaku hingga 2026). Beliau turut mendirikan JUVENIS pada tahun 2012 dan telah memilikinya sejak tahun 2021.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Assoc. Prof. Priv.-Doz. Dr. Alexander W. Hauswirth is a specialist in internal medicine and haemato‑oncology at JUVENIS. Since 2010, he has served as the lead senior physician for Haematology/Haemostaseology and Oncology at the Clinic for Internal Medicine I, Medical University of Vienna/AKH Vienna, Austria’s largest hospital.

He earned his medical degree from the University of Vienna in 1999. He received the venia docendi in 2010 and was appointed Associate Professor in 2012. He completed an additional haemato‑oncology qualification in 2014. As a Schrödinger Fellow in Salamanca in 2009–2010, he researched CLL stem and precursor cells. He has published regularly since 2000.

Accreditations include Austrian Medical Chamber diplomas in emergency medicine (since 2009) and sports medicine (2018). Awards include the Schrödinger Fellowship (2009), the ÖGHO award (2009), and the European Society of Chemotherapy poster award (2003). Clinical focus: anaemias, leukaemias, lymph node disorders, clotting and anticoagulation, and pre‑operative clearance. Languages: German and English.

OÄ Dr. med. Elli Katherina Greisenegger adalah seorang dermatolog dan venereolog di JUVENIS Medical Center, Wina. Beliau juga merupakan dokter senior di Klinik Universitas untuk Dermatologi, Rumah Sakit Universitas St. Pölten. Di sana, beliau memimpin klinik rawat jalan alergi. Beliau melayani konsultasi dalam bahasa Jerman, Inggris, Prancis, dan Yunani.

Pendidikan: Medical University of Vienna. Studi tahun 1997–2004. Gelar Doktor tahun 2006. Residensi di Kaiser-Franz-Josef dan Rudolfstiftung, 2007–2009. Pelatihan spesialis dermatologi dan venereologi di Klinik Universitas untuk Dermatologi, Medical University of Vienna, 2009–2014.

Akreditasi: Diploma genetika medis dari Asosiasi Medis Austria. Pelatih dermatitis atopik bersertifikat (AGNES). Diploma pendidikan berkelanjutan dari Asosiasi Medis Austria. Fokus klinis: skrining dan bedah kanker kulit; pengangkatan tahi lalat, kutil, dan lipoma; tes alergi (prick dan patch) serta imunoterapi spesifik; dermatitis atopik; jerawat, rosacea, dan hidradenitis suppurativa; kerontokan rambut; gangguan pigmentasi; infeksi jamur pada kulit dan kuku.

OÄ Dr. med. Tamara Arnoldner adalah spesialis dermatologi dan venereologi di JUVENIS Medical Center. Beliau bekerja di sana sebagai dokter pengganti pada Mei 2024 dan telah menjadi dokter mitra sejak Maret 2025. Beliau juga menjabat sebagai dokter senior di Departemen Dermatologi, Universitas Kedokteran Wina, sejak November 2024.

Pendidikan: M.D., Universitas Kedokteran Wina (2015). Pelatihan klinis dasar di Rudolfstiftung (2015–2016). Rotasi di Rumah Sakit Universitas St. Pölten (2016). Pelatihan spesialis dermatologi dan venereologi (2017–2022). Spesialisasi alergi sejak 2022. Pelatih dermatitis atopik bersertifikat (2017).

Fokus: dermatitis atopik; diagnosis dan pengobatan alergi (uji chip alergi, tes tusuk dan tempel, imunoterapi spesifik); kerontokan rambut; penyakit kulit inflamasi; skrining kanker kulit dan bedah dermatologi; jerawat, rosacea, hidradenitis; psoriasis; dermatologi estetika (toksin botulinum, asam hialuronat, mesoterapi, microneedling, terapi plasma). Beliau menyediakan perawatan medis dan estetika yang terintegrasi.

Dr. Christine Bangert adalah dokter spesialis dermatologi dan venereologi di JUVENIS di Wina dan dokter senior di Departemen Dermatologi, Universitas Kedokteran Wina. Beliau mengepalai Klinik Rawat Jalan Dermatitis Atopik. Sejak tahun 2011, beliau memimpin laboratorium imunopatologi untuk penyakit kulit lepuh di AKH Wina. Beliau memiliki pengalaman lebih dari 25 tahun di bidang kedokteran. Keahlian beliau mencakup eksim berat, penyakit autoimun kulit lepuh, dan alergi kompleks.

Pendidikan/akreditasi: studi kedokteran dan doktoral, Universitas Lübeck (2000). Izin praktik (2003). Asosiasi peneliti, Universitas Kedokteran Wina, Departemen Dermatologi (2001–2003). Pelatihan spesialis Dermatologi dan Venereologi, AKH Wina (2004–2011). Diploma Akupunktur, Masyarakat Akupunktur Austria (2008). Pelatih dermatitis atopik bersertifikat (2011).

Peran: dokter bangsal senior, AKH Wina (2011–2013). Dokter senior, Klinik Rawat Jalan Alergi (sejak 2013). Kepala, Klinik Rawat Jalan Dermatologi Anak (sejak 2014). JUVENIS (sejak 2015). Bahasa: Jerman, Inggris.

Dr. Shute Ailia DAE is a medical oncologist at Optimed International Çorlu Hospital. Dr. Ailia graduated from Dokuz Eylül University Faculty of Medicine in 2013 and completed an internal medicine residency at Bezmialem Vakıf University Hospital in 2018. A hematology–oncology fellowship at Başkent University Hospital followed in 2023.

From 2018 to 2020, Dr. Ailia served as an internal medicine specialist at Bezmialem Vakıf University Hospital. From 2023 to 2024, Dr. Ailia was an instructor in medical oncology at Başkent University Adana Dr. Turgut Noyan Practice and Research Center.

Clinical focus includes breast, lung, and prostate cancers. It also covers gastrointestinal cancers (colon, stomach, esophagus, pancreas, liver), lymphomas, melanoma, and gynecologic and genitourinary cancers. Languages: English, Turkish, Swahili.

Dr. Derya Can adalah asisten profesor dan dokter kulit di Rumah Sakit Universitas Medipol Pendik. Beliau berspesialisasi dalam tumor kulit, penyakit inflamasi, dan restorasi rambut. Dr. Can melakukan transplantasi rambut FUE dan menggunakan terapi PRP untuk kerontokan rambut. Beliau menangani 350.000 pasien setiap tahun di rumah sakit universitas dengan peringkat tinggi ini.

• Menangani kondisi kulit kompleks seperti psoriasis, jerawat parah, dan dermatitis atopik.
• Melakukan prosedur estetika termasuk Botox untuk pria dan perawatan bawah mata.
• Ahli dalam mengangkat tahi lalat atipikal maupun tumor kulit ganas.
• Melakukan biopsi kulit diagnostik dan dermatoskopi untuk deteksi penyakit yang akurat.

Dr. Saadet Unsal adalah dokter spesialis kebidanan dan kandungan di Rumah Sakit Universitas Medipol Pendik di Istanbul. Beliau menangani kondisi kesehatan wanita yang kompleks, termasuk fibroid rahim dan endometriosis. Dr. Unsal telah menerbitkan penelitian di jurnal SCI-Expanded mengenai manajemen gejala menopause. Beliau bekerja di rumah sakit yang melayani 350.000 pasien setiap tahun dengan skor kualitas tinggi.

• Melakukan prosedur onkologi ginekologi dan perawatan kedokteran estetika.
• Memberikan perawatan khusus untuk ovarium polikistik dan prolaps rahim.
• Keahliannya meliputi peremajaan kulit, terapi PRP, dan suntikan botox.
• Mempertahankan fokus klinis pada bedah rekonstruktif dan ginekologi preventif.